Here's the live share price of Anthem Biosciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Anthem Biosciences has gained 2.65% CAGR. Over the past year, the corresponding return has been 13.98%.
Anthem Biosciences’s current P/E of 0.00x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Anthem Biosciences | 1.77 | 13.19 | 14.06 | 14.06 | 14.06 | 4.46 | 2.65 |
Sun Pharmaceutical Industries | -0.33 | -2.66 | -5.61 | 0.43 | -12.93 | 21.44 | 25.3 |
Divi's Laboratories | -1.45 | -5.93 | -9.06 | 9.34 | 17.62 | 18.7 | 13.47 |
Cipla | -2.12 | 3.79 | 4.45 | 9.7 | -4.43 | 14.9 | 16.77 |
Torrent Pharmaceuticals | 0.55 | -0.3 | 13.82 | 20.01 | 3.94 | 33.04 | 20.79 |
Mankind Pharma | 3.25 | -2.49 | 8.07 | 11.51 | 3.29 | 21.46 | 12.37 |
Dr. Reddy's Laboratories | -0.16 | 3.88 | -2.24 | 11.93 | -5.86 | 14.32 | 7.33 |
Zydus Lifesciences | 2.83 | 5.05 | 5.55 | 13.64 | -9.55 | 39.53 | 22.18 |
Lupin | 2.32 | 3.96 | -2.92 | -3.61 | -15.35 | 43.7 | 15.94 |
Abbott India | -1.26 | -6.5 | -1.89 | -0.91 | 4.92 | 19.59 | 13.61 |
Alkem Laboratories | -0.23 | 7.58 | 9.29 | 12.73 | -15.71 | 20.34 | 13.41 |
Aurobindo Pharma | 1.1 | -3.8 | -10.39 | -4.88 | -32.21 | 24.35 | 5.5 |
Glenmark Pharmaceuticals | 6.48 | -0.12 | 29.27 | 47.76 | 19.88 | 76.68 | 34.41 |
Biocon | 3.69 | -3.06 | 9.22 | 11.24 | -5.66 | 7.2 | -3.1 |
Laurus Labs | 2.84 | 2.72 | 37.46 | 55.44 | 80.09 | 16.01 | 29.63 |
GlaxoSmithKline Pharmaceuticals | 0.29 | -1.71 | -19.31 | 3.7 | -0.75 | 24.72 | 11.45 |
Cohance Lifesciences | 3.43 | -5.36 | -14.44 | -22.6 | -20.96 | 22.55 | 21.89 |
Ipca Laboratories | -3.23 | -6.29 | -3.65 | -1.98 | -7.42 | 14.65 | 5.56 |
Ajanta Pharma | 5.64 | -0.68 | 1.68 | 2.27 | -21.35 | 24.63 | 20.78 |
Gland Pharma | 2.57 | -2.52 | 17.47 | 21.5 | 1.27 | -8.22 | 0.97 |
Over the last one year, Anthem Biosciences has gained 14.06% compared to peers like Sun Pharmaceutical Industries (-12.93%), Divi's Laboratories (17.62%), Cipla (-4.43%). From a 5 year perspective, Anthem Biosciences has underperformed peers relative to Sun Pharmaceutical Industries (25.30%) and Divi's Laboratories (13.47%).
Day | SMA | EMA |
---|---|---|
5 | 818.05 | 817.94 |
10 | 826.1 | 815.48 |
20 | 791.59 | 800.89 |
50 | 467.43 | 0 |
100 | 233.72 | 0 |
200 | 116.86 | 0 |
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Quant Small Cap Fund | 36,82,926 | 0.95 | 279.59 |
Kotak Small Cap Fund - Regular Plan | 21,65,460 | 0.92 | 164.39 |
HSBC Midcap Fund | 21,11,545 | 1.35 | 160.3 |
SBI Magnum Global Fund | 16,00,000 | 1.96 | 121.46 |
Axis ELSS Tax Saver Fund | 13,00,649 | 0.28 | 98.74 |
SBI Healthcare Opportunities Fund | 12,00,000 | 2.26 | 91.1 |
HDFC Business Cycle Fund | 11,88,001 | 3.08 | 90.19 |
Nippon India Pharma Fund | 10,58,503 | 0.92 | 80.36 |
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 10,52,636 | 1.31 | 79.91 |
Quant Mid Cap Fund | 10,40,851 | 0.9 | 79.02 |
Date Time | Announcement |
---|---|
Aug 18, 2025, 9:38 PM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
Aug 14, 2025, 9:27 PM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
Aug 14, 2025, 3:29 AM IST | Anthem Biosciences - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot |
Aug 14, 2025, 2:47 AM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Investor Presentation |
Aug 14, 2025, 2:41 AM IST | Anthem Biosciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release |